In Brief: Chiron
Chiron: CEO search launched. Current president and CEO Edward Penhoet, PhD, becomes vice chairman of the board. Penhoet will be responsible for policy development, and government and industry relations. Chairman William Rutter, PhD, will relinquish some operating responsibilities to the new CEO and continue to be involved in strategic planning and implementation. Rutter will have responsibility for Chiron Technologies and other research operations...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth